| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/28/2004 | CN1147299C Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 04/28/2004 | CN1147294C Pentafluorobenzenesulfonamides and analogs |
| 04/27/2004 | US6727274 Use in treating conditions in which 5-ht6 receptors are involved such as anxiety, depression, schizophrenia, alzheimer's disease, stress-related disease, nervous system disorders; use in performing positron emission tomography |
| 04/27/2004 | US6727270 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727246 Enhancement of cognition and memory in human diseases such as alzheimer's |
| 04/27/2004 | US6727237 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate |
| 04/27/2004 | US6727041 Optical recording media |
| 04/27/2004 | CA2104214C Cytokine inhibitors |
| 04/22/2004 | WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/22/2004 | WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 04/22/2004 | WO2004033397A2 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | WO2004032921A1 Indole derivatives as beta-2 agonists |
| 04/22/2004 | WO2004032871A2 Piperazine and piperazinone inhibitors of factor xa |
| 04/22/2004 | WO2004014300A3 Tyrosine kinase inhibitors |
| 04/22/2004 | WO2002098857A8 New indole derivatives with 5-ht6 receptor affinity |
| 04/22/2004 | US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings |
| 04/22/2004 | US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector |
| 04/22/2004 | US20040077726 Antiproliferative and anticarcinogenic agents; psoriasis |
| 04/22/2004 | US20040077705 Cyclopentyl indole derivatives |
| 04/22/2004 | US20040077704 Fused cyclopenta-, cyclohexa-, or cyclohepta(g)indole derivatives as human non-pancreatic secretory phospholipase inhibitors; antiinflammatory agents |
| 04/22/2004 | US20040077698 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors |
| 04/22/2004 | US20040077694 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077691 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 04/22/2004 | US20040077685 Analogs of thalidomide as potential angiogenesis inhibitors |
| 04/22/2004 | US20040077646 Indole nitriles |
| 04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
| 04/22/2004 | US20040077619 Calcium receptor modulating agents |
| 04/22/2004 | DE10153346A1 Substituierte Indole Substituted indoles |
| 04/22/2004 | CA2501831A1 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/21/2004 | EP1411047A1 Intercalators having affinity for DNA and methods of use |
| 04/21/2004 | EP1409578A1 Method of mass-colouring synthetic materials |
| 04/21/2004 | EP1409516A2 Aromatic sulfenates for type i phototherapy |
| 04/21/2004 | EP1409482A2 Dye-sulfenates for dual phototherapy |
| 04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
| 04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1408970A1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 04/21/2004 | EP1408963A1 2- 5-(5-CARBAMIMIDOYL-1 i H /i -HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS |
| 04/21/2004 | EP1408962A1 Substituted isoindoles and the use thereof |
| 04/21/2004 | EP1408960A1 Benz-indole and benzo-quinoline derivatives as prodrugs for tumour treatment |
| 04/21/2004 | EP1408937A2 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 04/21/2004 | EP1208077B1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds |
| 04/21/2004 | EP1196381B1 Process for the preparation of n-(1,1-dimethylethyl)-4-((5'-ethoxy-4-cis-(2-(4-morpholino)ethoxy)-2'-oxospiro(cyclohexan-1,3'-(3h)indol)-1'(2'h)-yl)-sulfonyl)-3-methoxybenzamide and its salts |
| 04/21/2004 | EP1057813B1 Indole derivatives and medicinal compositions containing the same |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | EP0800831B1 Diagnostic marker |
| 04/21/2004 | CN1491223A 3-indoline derivatives useful in treatment of psychiatric and neurologic disorders |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1490312A Carbazole derivative and its application in electroluminescent device |
| 04/21/2004 | CN1146556C 1,2-dihydroindene or indoline derivatives, preparation and use thereof |
| 04/21/2004 | CN1146539C Process for preparing sparingly soluble aromatic amines |
| 04/20/2004 | US6723798 Combinatorial chemistry; hydroxyphenylalkyl vinyl ether linking group to divinylbenzene-styrene polymer |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723744 Indole carboxylic acids as thyroid receptor ligands |
| 04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
| 04/20/2004 | US6723725 Indole derivatives |
| 04/15/2004 | WO2004031405A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | WO2004031384A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | WO2004031248A1 Novel nitrosation polymer in organic synthesis |
| 04/15/2004 | WO2004031129A2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 04/15/2004 | WO2004030635A2 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2003083063A3 Common ligand mimics: naphtoates |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040073042 Control agents for living-type free radical polymerization and methods of polymerizing |
| 04/15/2004 | US20040073014 Fluorescent dyes, energy transfer couples and methods |
| 04/15/2004 | US20040072907 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 04/15/2004 | US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 04/15/2004 | US20040072890 Anticancer agents |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072844 2,4-Substituted indoles and methods of use |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 04/15/2004 | US20040072693 3-aminocarbonyl substituted benzoylpyrazolones |
| 04/15/2004 | US20040072209 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 04/15/2004 | US20040072018 For use in electroluminescent material |
| 04/15/2004 | DE10257188B3 Preparation of meso-substituted cyanine dye, for radiation-sensitive coating, e.g. for making printing plate, printed circuit boards or DVD, from 2-halo-cyclo-pentene or -hexene-dianil involves 1-stage introduction of end and meso-groups |
| 04/15/2004 | DE10195974T5 Neue substituierte Calix-(4)-Pyrrole und Verfahren für die Synthese der Calix-(4)-Pyrrole über Molekularsiebkatalysatoren New substituted calix (4) pyrroles and procedures for the synthesis of calix (4) pyrroles over molecular sieve catalysts |
| 04/15/2004 | CA2501063A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | CA2500935A1 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 04/15/2004 | CA2500883A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | CA2500754A1 Novel nitrosation polymer in organic synthesis |
| 04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
| 04/14/2004 | EP1408090A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 04/14/2004 | EP1408032A2 Coupling product between tryptamine and an alpha-amino acid and its use in the field of neuro-cosmetics |
| 04/14/2004 | EP1407769A1 Indole derivatives as beta-2 agonists |
| 04/14/2004 | EP1406983A1 Tertiary diamines containing heterocyclic groups and their use in organic electroluminescent devices |
| 04/14/2004 | EP1406870A1 Taxol enhancer compounds |
| 04/14/2004 | EP1406869A1 Taxol enhancer compounds |
| 04/14/2004 | EP1406868A1 Synthesis of taxol enhancers |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406859A1 Substituted 4-aminocyclohexanol derivatives |
| 04/14/2004 | EP1406858A1 Substituted 4-aminocyclohexanols |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |